Literature DB >> 26209387

Dengue infection associated hemophagocytic syndrome: Therapeutic interventions and outcome.

Wan Fariza Wan Jamaludin1, Petrick Periyasamy2, Wan Rahiza Wan Mat3, S Fadilah Abdul Wahid4.   

Abstract

Infection associated hemophagocytic syndrome is increasingly recognized as a potentially fatal complication of dengue fever. It should be suspected with prolonged fever beyond seven days associated with hepatosplenomegaly, hyperferritinemia, worsening cytopenias and development of multiorgan dysfunction. Surge of similar pro-inflammatory cytokines observed in dengue associated hemophagocytic syndrome and multiorgan dysfunction may indicate they are part of related inflammatory spectrum. A proportion of patients recovered with supportive therapy, however most required interventions with corticosteroids, intravenous immunoglobulin or chemotherapy. We report three cases of dengue associated IAHS with good outcome following early recognition and treatment with dexamethasone and intravenous immunoglobulin.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Corticosteroids; Dengue; Hemophagocytic syndrome; Intravenous immunoglobulin

Mesh:

Substances:

Year:  2015        PMID: 26209387     DOI: 10.1016/j.jcv.2015.06.004

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  13 in total

1.  Prolonged fever and pancytopenia in a case of severe dengue may be secondary hemophagocytic lymphohistiocytosis.

Authors:  Vijoy Kumar Jha; Harshit Khurana; A Balakrishnan
Journal:  Med J Armed Forces India       Date:  2020-08-05

2.  Incidence and Risk Factors for Developing Dengue-Associated Hemophagocytic Lymphohistiocytosis in Puerto Rico, 2008 - 2013.

Authors:  Esther M Ellis; Tyler M Sharp; Janice Pérez-Padilla; Liza González; B Katherine Poole-Smith; Emmaculate Lebo; Charlotte Baker; Mark J Delorey; Brenda Torres-Velasquez; Eduardo Ochoa; Brenda Rivera-Garcia; Hector Díaz-Pinto; Luis Clavell; Anabel Puig-Ramos; Gritta E Janka; Kay M Tomashek
Journal:  PLoS Negl Trop Dis       Date:  2016-08-24

3.  Severe dengue due to secondary hemophagocytic lymphohistiocytosis: A case study.

Authors:  Ujjwayini Ray; Soma Dutta; Susovan Mondal; Syamasis Bandyopadhyay
Journal:  IDCases       Date:  2017-03-30

4.  Dengue Infection Complicated by Hemophagocytic Lymphohistiocytosis: Experiences From 180 Patients With Severe Dengue.

Authors:  Foong Kee Kan; Cheng Cheng Tan; Tatiana Von Bahr Greenwood; Khairil E Khalid; Premaa Supramaniam; Ida Hed Myrberg; Lian Huat Tan; Jan-Inge Henter
Journal:  Clin Infect Dis       Date:  2020-05-23       Impact factor: 9.079

Review 5.  Recent advances in understanding dengue.

Authors:  Scott Halstead
Journal:  F1000Res       Date:  2019-07-31

6.  Dengue death with evidence of hemophagocytic syndrome and dengue virus infection in the bone marrow.

Authors:  Hasliana Azrah Ab-Rahman; Pooi-Fong Wong; Hafiz Rahim; Juraina Abd-Jamil; Kim-Kee Tan; Syuhaida Sulaiman; Chai-See Lum; Syarifah-Faridah Syed-Omar; Sazaly AbuBakar
Journal:  Springerplus       Date:  2015-11-02

7.  Dengue fever as a cause of hemophagocytic lymphohistiocytosis.

Authors:  Noely Hein; Gabriel Heiser Bergara; Nathalie Bianchini Vieira Moura; Débora Morais Cardoso; Maki Hirose; Angela Espósito Ferronato; Antônio Carlos Pastorino; Denise Swei Lo; Alfredo Elias Gilio
Journal:  Autops Case Rep       Date:  2015-09-30

Review 8.  Dengue-associated hemophagocytic lymphohistiocytosis in an adult: A case report and literature review.

Authors:  Sang Mi Chung; Joon Young Song; Wonshik Kim; Min Joo Choi; Ji Ho Jeon; Seonghui Kang; Eunju Jung; Ji Yun Noh; Hee Jin Cheong; Woo Joo Kim
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.817

Review 9.  Differential diagnosis of multiple sclerosis in Latin America.

Authors:  Y D Fragoso; F G Elso; A Carrá
Journal:  Mult Scler J Exp Transl Clin       Date:  2017-09-25

10.  Macrophage Activation Marker Soluble CD163 Associated with Fatal and Severe Ebola Virus Disease in Humans1.

Authors:  Anita K McElroy; Punya Shrivastava-Ranjan; Jessica R Harmon; Roosecelis B Martines; Luciana Silva-Flannery; Timothy D Flietstra; Colleen S Kraft; Aneesh K Mehta; G Marshall Lyon; Jay B Varkey; Bruce S Ribner; Stuart T Nichol; Sherif R Zaki; Christina F Spiropoulou
Journal:  Emerg Infect Dis       Date:  2019-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.